[1] CHITI F, DOBSON C M. Protein misfolding, functional amyloid, and human disease[J]. Annu Rev Biochem,2006, 75: 333-366. DOI: 10.1146/annurev.biochem.75.101304.123901. [2] 徐萍,刘超.胰淀素、胰岛淀粉样蛋白沉积与2型糖尿病[J]. 医学综述,2005, 11: 500-502. [3] 金玲,杨慧.α-Synuclein聚集与帕金森病影响α-synuclein蛋白聚集的因素[J]. 生物化学与生物物理进展,2006, 33(4): 321-328. JIN L,YANG H.α-Synuclein aggregation and parkinson’s disease: factors affecting the aggregation of α-synuclein[J]. Prog Biochem Biophys, 2006, 33(4): 321-328. [4] 张岚,杨延莲,王琛.调节分子对β淀粉样蛋白的聚集调控及细胞毒性抑制效应[J]. 生物物理学报, 2010, 26(8): 649-661. ZHANG L,YANG Y L,WANG C.Regulation of aggregation and cytotoxicity of β-Amyloid by molecular modulators[J]. ACTA Biophysica Sinica, 2010, 26(8): 649-661. [5] LIU W R, LANGER R,KLIBANOV A M. Moisture-induced aggregation of lyophilized proteins in the solid state[J]. Biotechnol Bioeng, 1991, 37: 177-184. DOI:10.1002/bit.260370210. [6] COSTANTINO H R, LANGER R, KLIBANOV A M. Moisture-induced aggregation of lyophilized insulin[J]. Pharm Res,1994, 11: 21-29. DOI: 10.1023/A:1018981208076. [7] KATAKAM M, BELL L N, BANGA A K. Effect of surfactants on the physical stability of recombinant human growth hormone[J]. J Pharm Sci, 1995, 84: 713-716. DOI:10.1002/jps.2600840609. [8] KREILGAARD L,FROKJAER S,FLINK J M, et al. Effects of additives on the stability of Humicola lanuginosa lipase during freeze-drying and storage in the dried solid[J]. J Pharm Sci, 1999, 88: 281-290. DOI:10.1021/js980399d [9] GEORGIOU G, VALAX P. Isolating inclusion bodies from bacteria[J]. Methods Enzymol, 1999, 309: 48. [10] ROBERTS C J.Kinetics of irreversible protein aggregation: analysis of extended Lumry-Eyring models and implications for predicting protein shelf life[J]. J Phys Chem B,2003, 107: 1194-1207. DOI: 10.1021/jp026827s. [11] FROKJAER S, OTZEN D E.Protein drug stability: a formulation challenge[J]. Nat Rev Drug Discovery,2005, 4: 298-306. DOI: 10.1038/nrd1695. [12] WANG W. Protein aggregation and its inhibition in biopharmaceutics[J]. Int J Pharm,2005, 289: 1-30. DOI: 10.1016/j.ijpharm.2004.11.014. [13] ROSENBERG A S. Effects of protein aggregates: an immunologic perspective[J]. The AAPS journal,2006, 8: E501-E507. DOI:10.1208/aapsj080359. [14] CROMWELL M E, HILARIO E, JACOBSON F. Protein aggregation and bioprocessing[J]. The AAPS Journal,2006, 8: E572-E579. DOI: 10.1208/aapsj080366. [15] MAHLER H C, FRIESS W, GRAUSCHOPF U, et al. Protein aggregation: pathways, induction factors and analysis[J]. J Pharm Sci, 2009, 98: 2909-2934. DOI: 10.1002/jps.21566. [16] WANG W, NEMA S, TEAGARDEN D. Protein aggregation-Pathways and influencing factors[J]. Int J Pharm,2010, 390: 89-99. DOI: 10.1016/j.ijpharm.2010.02.025. [17] ENGELSMAN J, GARIDEL P, SMULDERS R,et al. Strategies for the assessment of protein aggregates in pharmaceutical biotech product development[J]. Pharm Res,2011, 28: 920-933. DOI: 10.1007/s11095-010-0297-1. [18] CAO A, HU D, LAI L H. Formation of amyloid fibrils from fully reduced hen egg white lysozyme[J]. Protein Sci,2004, 13: 319-324. DOI: 10.1110/ps.03183404. [19] 李昊一, 李冬敏, 马刚, 等. 牛血清白蛋白聚集体的分解动力学[J]. 河北大学学报(自然科学版), 2016, 36(1): 35-42. DOI: 10. 3969 /j. issn. 1000-1565. 2016. 01. 007. LI H Y, LI D M, MA G, et al. Structural insights into bovine serum albumin aggregates by a dissociation kinetic investigation[J]. Journal of Hebei University(Natural Science Edition), 2016, 36(1): 35-42. DOI: 10. 3969 /j. issn. 1000-1565. 2016. 01. 007. [20] SUMIE YOSHIOKA, YUKIO ASO, KOJIMA S. Usefulness of the kohlrausch-williams-watts stretched exponential function to describe protein aggregation in lyophilized formulations and the temperature dependence near the glass transition temperature[J]. Pharm Res,2001, 18: 256-260. DOI:10.1023/A:1011082309058. [21] JUÁREZ J, LÓPEZ S G, CAMBÓN A, et al. Influence of electrostatic interactions on the fibrillation process of human serum albumin[J]. J Chem Phys, 2009, 113: 10521-10529. DOI: 10.1021/jp902224d. |